Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan.
Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan.
J Endocrinol. 2021 Mar;248(3):317-324. doi: 10.1530/JOE-20-0442.
Carbohydrate response element-binding protein (ChREBP) is critical in the regulation of fatty acid and triglyceride synthesis in the liver. Interestingly, Chrebp-/- mice show reduced levels of plasma cholesterol, which is critical for steroid hormone synthesis in adrenal glands. Furthermore, Chrebp mRNA expression was previously reported in human adrenal glands. Thus, it remains to be investigated whether ChREBP plays a role directly or indirectly in steroid hormone synthesis and release in adrenal glands. In the present study, we find that Chrebp mRNA is expressed in mouse adrenal glands and that ChREBP binds to carbohydrate response elements. Histological analysis of Chrebp-/- mice shows no adrenal hyperplasia and less oil red O staining compared with that in WT mice. In adrenal glands of Chrebp-/- mice, expression of Fasn and Scd1, two enzymes critical for fatty acid synthesis, was substantially lower and triglyceride content was reduced. Expression of Srebf2, a key transcription factor controlling synthesis and uptake of cholesterol and the target genes, was upregulated, while cholesterol content was not significantly altered in the adrenal glands of Chrebp-/- mice. Adrenal corticosterone content and plasma adrenocorticotropic hormone and corticosterone levels were not significantly altered in Chrebp-/- mice. Consistently, expression of genes related to steroid hormone synthesis was not altered. Corticosterone secretion in response to two different stimuli, namely 24-h starvation and cosyntropin administration, was also not altered in Chrebp-/- mice. Taking these results together, corticosterone synthesis and release were not affected in Chrebp-/- mice despite reduced plasma cholesterol levels.
碳水化合物反应元件结合蛋白(ChREBP)在肝脏中脂肪酸和甘油三酯合成的调节中起着关键作用。有趣的是,Chrebp-/- 小鼠的血浆胆固醇水平降低,这对于肾上腺类固醇激素的合成至关重要。此外,先前已有报道 Chrebp mRNA 在人肾上腺中表达。因此,ChREBP 是否直接或间接参与肾上腺类固醇激素的合成和释放仍有待研究。在本研究中,我们发现 Chrebp mRNA 在小鼠肾上腺中表达,并且 ChREBP 与碳水化合物反应元件结合。Chrebp-/- 小鼠的组织学分析显示,与 WT 小鼠相比,肾上腺没有增生,油红 O 染色较少。在 Chrebp-/- 小鼠的肾上腺中,两种关键的脂肪酸合成酶 Fasn 和 Scd1 的表达显著降低,甘油三酯含量减少。控制胆固醇合成和摄取以及靶基因的关键转录因子 Srebf2 的表达上调,而 Chrebp-/- 小鼠肾上腺中的胆固醇含量没有明显改变。Chrebp-/- 小鼠的肾上腺皮质酮含量、血浆促肾上腺皮质激素和皮质酮水平没有明显改变。一致地,与类固醇激素合成相关的基因表达也没有改变。Chrebp-/- 小鼠对两种不同刺激(即 24 小时饥饿和促皮质素给药)的皮质酮分泌也没有改变。综合这些结果,尽管血浆胆固醇水平降低,Chrebp-/- 小鼠的皮质酮合成和释放没有受到影响。